![Sergio Lociuro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sergio Lociuro
Fundador en THOT Consulting Sagl .
Perfil
Sergio Lociuro is the founder of THOT Consulting Sagl.
He currently works as a Director at Arpida A.
Previously, he worked as a Director-Medicinal Chemistry at GlaxoSmithKline AG, Head-Peptide Mimetics Business Unit at Spexis Ltd., Head-Research at Evolva Holding SA, Chief Scientific Officer at Caerus Consulting AS and Adenium Biotech ApS, and Manager-Research & Development at Sanofi-Aventis New Zealand Ltd.
He received his undergraduate degree from The American University of Rome in 1981 and his doctorate degree from the University of New Brunswick in 1987.
Cargos activos de Sergio Lociuro
Empresas | Cargo | Inicio |
---|---|---|
THOT Consulting Sagl | Fundador | - |
Arpida A/S | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Sergio Lociuro.
Empresas | Cargo | Fin |
---|---|---|
Sanofi-Aventis New Zealand Ltd. | Director Técnico/Científico/I+D | - |
EVOLVA HOLDING SA | Director Técnico/Científico/I+D | - |
SPEXIS AG | Corporate Officer/Principal | - |
Adenium Biotech ApS
![]() Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark. | Director Técnico/Científico/I+D | - |
GlaxoSmithKline AG
![]() GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a company based in Munchenbuchsee, Switzerland. | Corporate Officer/Principal | - |
Formación de Sergio Lociuro.
University of New Brunswick | Doctorate Degree |
The American University of Rome | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SPEXIS AG | Health Technology |
EVOLVA HOLDING SA | Consumer Non-Durables |
Empresas privadas | 6 |
---|---|
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
GlaxoSmithKline AG
![]() GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a company based in Munchenbuchsee, Switzerland. | Health Technology |
Adenium Biotech ApS
![]() Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
THOT Consulting Sagl | |
Arpida A/S | |
Sanofi-Aventis New Zealand Ltd. |
- Bolsa de valores
- Insiders
- Sergio Lociuro